article thumbnail

Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?

Reprocell

REPROCELL has led the way in mRNA reprogramming, in 2010 becoming the first company to commercialize mRNA-based reprogramming technologies. The Power of mRNA Reprogramming The emergence of mRNA reprogramming offers a precise, efficient, and xeno-free approach to generating induced pluripotent stem cells (iPSCs).

article thumbnail

Why radiopharmaceuticals are gaining ground in the fight against cancer

Drug Target Review

RMX initiated the first IND for Lu-177 dotatate in the US for NETs at Excel Diagnostic Oncology Center, where we treated our first patient in August 2010,” he recalls. He references early work from Erasmus University in the 2000s as a turning point, where researchers were targeting NETs using lutetium-177 dotatate (Lu-177).

Therapies 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy

Broad Institute

In 2010, cells grown by June and Levine were used to treat leukemia and lymphoma patients. We ran the assay three times to convince ourselves that the tumor cells were indeed gone. That was the eureka moment a moment of total marvel when we contemplated such an outcome. A single dose of the engineered cells wiped out signs of disease.

Therapies 119
article thumbnail

Time for change: non-human primates in drug research

Drug Target Review

European Directive 2010/63/EU on the protection of animals used for scientific purposes. References Animal Legal Defense Fund v. USDA (2020). Federal ruling on USDA primate welfare petition, 2023. National Research Council. Guide for the Care and Use of Laboratory Animals. NIH Office of Laboratory Animal Welfare – Training Guidelines.

article thumbnail

Navigating Regulatory Hurdles in Drug Development

DrugBank

The FDA restricted its use in 2010, requiring additional studies before partially lifting restrictions in 2013.    Another example of regulatory scrutiny involved GlaxoSmithKline’s Avandia , a diabetes medication linked to cardiovascular risks.

article thumbnail

Syringe services for people who inject drugs are enormously effective, but remain underused

National Institute on Drug Abuse: Nora's Blog

2010 Oct 8; accessed on November 13, 2024: apo-nid22857.pdf Impact of an unsanctioned safe consumption site on criminal activity, 2010-2019. Trends in property and illicit drug crime around the medically supervised injecting centre in Kings Cross: an update. NSW Bureau of Crime Statistics and Research. Drug Alcohol Depend.

Drugs 119
article thumbnail

Atlas XIV And Reflections On The VC Math Problem

LifeSciVC

When I joined in 2005, the “patient” (Atlas) was undergoing surgery and we came out of the decade in 2010 with a small partnership, around one table, in one office in Cambridge. In 2014, we simplified further by focusing Atlas only on biotech.